Clinical Observation of Rivastigmine Combined with Lipoic Acid in the Treatment of Alzheimer's Disease

@inproceedings{Lei2013ClinicalOO,
  title={Clinical Observation of Rivastigmine Combined with Lipoic Acid in the Treatment of Alzheimer's Disease},
  author={Lu Lei},
  year={2013}
}
OBJECTIVE:To observe clinical efficacy and safety of rivastigmine combined with lipoic acid(LA) in the treatment of Alzheimer's disease.METHODS:90 patients with Alzheimer's disease were randomly divided into rivastigmine group and trail group;rivastigmine group were assigned to receive rivastigmine and trial group to receive LA additionally on the basis of rivastigmine.At baseline and after 8 and 16 weeks treatment,the patients were assessed by MMSE,ADL scale,ADAS-cog scale and the scores of… CONTINUE READING

Similar Papers

Topics from this paper.